What Arcis Capital Partners does

Quartus Capital Partners is a privately held growth equity investment firm that deploys capital into growth-stage AI and technology companies. The firm invests across Series A through Series C, holding eight disclosed portfolio positions spanning AI-driven adaptive learning (Area9 Lyceum), single-use medical endoscopes (Integrated Endoscopy), AI for chronic disease management (uMethod Health), neuro-health diagnostics (NeuroSync Health), 3D LiDAR physical security (Quanergy Solutions), emerging-market logistics technology (Wahyd Group), enterprise travel and meetings analytics (Cerebri AI), and sustainable recycling of computer chips and precious metals (Greene Lyon Group). The firm's stated investment thesis is inspired by Cambridge Associates' growth equity framework, combining the upside potential of venture capital with the downside risk protections of buyouts, and it positions itself as a hands-on operator-investor that applies "growth and performance improvement expertise" to transform portfolio companies into market leaders.

The firm is founder-led by Afzal M. Tarar (Founder, CEO & Managing Partner), with a leadership team described as "AI pioneers, technologists, and seasoned operators with on average 20+ years of experience." It operates a bilateral footprint with headquarters in New York (135 West 41st Street, 5th Floor) and a regional office in Hong Kong (23/F Lee Garden Two, Causeway Bay), enabling cross-border deal sourcing into North America, Europe, and Asia/emerging markets. Beyond direct investments, Quartus has built a content and distribution platform around AI investing — including the "AI Value Playbook" framework, an AI deal-sourcing and due-diligence masterclass, and speaking appearances at forums such as FIN Forum 2025 — supported by a public deal submission portal that drives inbound deal flow.

Quartus's revenue model is characteristic of an alternative asset manager: returns are generated via equity investments in growth-stage AI and technology companies, with revenue mechanics implicitly driven by management fees on committed capital and carried interest on realized gains. The firm does not publicly disclose fund size, AUM, or revenue, and it has no disclosed parent company, institutional sponsor, or external ownership. No public funding rounds, M&A, or structural transactions are reported. Note: the input's company name (Arcis Capital Partners in the firmographics) differs from the source-materials' company name (Quartus Capital Partners); all source-derived facts in this analysis describe Quartus Capital Partners LLC.

Name

Arcis Capital Partners

Legal name

Quartus Capital Partners LLC

Website

https://arciscap.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

11–50 employees

Short description

Quartus Capital Partners is a privately held, founder-led growth equity firm investing in growth-stage AI and technology companies across Series A through Series C, with offices in New York and Hong Kong and a portfolio of eight disclosed companies across AI, medtech, neuro health, security, logistics, and sustainable tech.

Ownership category

akta.pro rank

Product category

Growth Equity Investment

NAICS

Portfolio Management and Investment Advice (523940), All Other Financial Investment Activities (52399)

SIC

Investment Advice (6282)

akta.pro primary industry

Technology & Software Growth Equity (FSANACAA)

akta.pro secondary industry

Multi-Sector / Generalist Growth Equity (FSANACAO)

Keywords

• Growth equity investment
• Venture capital services
• Technology venture investing
• Private equity firm
• Portfolio management

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations

Revenue model

1. Investment Returns: Returns generated through equity investments in growth-stage AI and technology companies, including Series A through Series C investments in portfolio companies.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Arcis Capital Partners is a growth equity investment firm that invests in growth-stage AI and technology ventures, primarily through Series A through Series C funding rounds. The firm applies growth and performance improvement expertise to transform portfolio companies into market leaders, combining the upside potential of venture capital with the downside risk protections of buyouts.

Product overview

Quartus Capital Partners is a growth equity investment firm that operates as a single, unified investment platform. The firm specializes in investing in growth-stage AI and technology ventures, offering investment services across multiple portfolio companies including Area9 Lyceum (AI-based adaptive learning), Integrated Endoscopy (single-use endoscopes), uMethod Health (AI engine for chronic disease management), NeuroSync Health (AI-based neuro health diagnostics), Quanergy Solutions (3D LiDAR security), Wahyd Group (logistics technology), Cerebri AI (business travel analytics), and Greene Lyon Group (recycling technologies). The investment strategy combines venture capital upside potential with buyout-style downside risk protections.

Differentiator

Problem solved

Functional benefit

Products and services

• Growth Equity Investment Services Investment and operational support services for growth-stage AI and technology companies. The firm provides capital and growth/performance improvement expertise to transform portfolio companies into market leaders. Portfolio includes Area9 Lyceum, Integrated Endoscopy, uMethod Health, NeuroSync Health, Quanergy Solutions, Wahyd Group, Cerebri AI, and Greene Lyon Group.

Named customers8 records

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators2 records

Expansion highlights4 records

Market position

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/quartuscap

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Arcis Capital Partners